Skip to main content

Candriam S.C.A.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1537014 STRASSEN, N4

Position in NBIX

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$36,236,931
-$5,332,874 QoQ
Shares Held
275,064
-6.2% QoQ
Ownership
0.274%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Candriam S.C.A. holds $163,728,631 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (22.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
275,064 $36,236,931

All Filings in NBIX

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $36,236,931 275,064
2025-12-31 $41,569,805 293,096
2025-09-30 $40,379,605 287,645
2025-06-30 $37,524,875 298,551
2025-03-31 $36,590,904 330,840
2024-12-31 $41,492,178 303,972
2024-09-30 $55,679,028 483,241
2024-06-30 $64,080,841 465,467
2024-03-31 $43,539,137 315,684
2023-12-31 $48,737,892 369,899
2023-09-30 $42,439,275 377,238
2023-06-30 $41,531,228 440,416
2023-03-31 $42,226,959 417,180
2022-12-31 $32,149,903 269,172
2022-09-30 $28,833,997 271,481
2022-06-30 $32,258,958 330,929
2022-03-31 $28,144,406 300,207
2021-12-31 $26,395,290 309,913
2021-09-30 $7,817,911 81,513
2021-06-30 $7,930,898 81,493
2021-03-31 $58,350 600
2021-03-31 $15,741,760 161,869
2020-12-31 $57,510 600
2020-12-31 $15,515,143 161,869
2020-09-30 $15,028,077 156,282
2020-06-30 $19,066,404 156,282
2020-03-31 $16,164,597 186,766